Clinical Trial Update: All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating all-trans retinoic acid (ATRA) for recurrent/metastatic adenoid cystic carcinoma of the head and neck.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma of the Head and Neck

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Adenoid Cystic Carcinoma of the Head and Neck | Phase 2 | Status: UNKNOWN